OrbiMed Capital GP VI LLC, 10% Owner at Kala Pharmaceuticals, Inc. (KALA), bought 385,080 shares at $15.00 ($5.8M) on 2018-01-31, disclosed to the SEC on 2018-02-02.
Open-market purchase of $5.8M KALA by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.00 | 339,400 | $5.1M | 88.1% |
| 2 | $14.99 | 22,840 | $342K | 5.9% |
| 3 | $14.99 | 22,840 | $342K | 5.9% |
| Total | $15.00 avg | 385,080 | $5.8M | 100% |
| Filing → |
| IRON | SELL | 2025-03-12 | $32.4M | — | Filing → |
| SCPH | BUY | 2024-08-15 | $2.0M | — | Filing → |
| NPCE | SELL | 2024-04-18 | $435K | — | Filing → |